BRNS

Barinthus Biotherapeutics plc.

Insider trading activity for Barinthus Biotherapeutics plc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 56 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 9	Oxford Science Enterpris…	former 10% owner	UTENDR↺	8.8M	$0.111	$976.6K	-100.0%	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS◆	20,394	—	—	—	Open the original filing on SEC.gov
Sep 9	Wright Robin	Director	DTOISS	48,256	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS◆	20,394	—	—	—	Open the original filing on SEC.gov
Sep 9	Morgon Pierre A.	Director	DTOISS	10,506	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Phillips Anne M.	Director	DTOISS	3,000	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Scheeren Joseph	Director	DTOISS	23,000	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS◆	600,000	—	—	—	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS◆	443,981	—	—	—	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS◆	440,000	—	—	—	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS◆	359,605	—	—	—	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS◆	176,130	—	—	—	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS	514,923	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Enright William	Chief Executive Officer	DTOISS	728,454	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Hammacher Alex	Director	DTOISS	3,000	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Hooftman Leon	Chief Medical Officer	DTOISS◆	140,000	—	—	—	Open the original filing on SEC.gov
Sep 9	Hooftman Leon	Chief Medical Officer	DTOISS◆	195,166	—	—	—	Open the original filing on SEC.gov
Sep 9	Hooftman Leon	Chief Medical Officer	DTOISS	361,530	—	—	-100.0%	Open the original filing on SEC.gov
Sep 9	Hooftman Leon	Chief Medical Officer	AGRANT	361,530	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS◆	20,174	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS◆	19,516	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS◆	19,197	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS◆	18,604	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS◆	34,328	—	—	—	Open the original filing on SEC.gov
Sep 9	Dawes Karen A	Director	DTOISS	1,700	—	—	-100.0%	Open the original filing on SEC.gov
Jun 10, 2025	Hammacher Alex	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Wright Robin	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Morgon Pierre A.	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Phillips Anne M.	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Scheeren Joseph	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Dawes Karen A	Director	AGRANT◆	20,174	—	—	—	Open the original filing on SEC.gov

UTENDR↺$976.6K

Oxford Science Enterpris… · former 10% ownerSep 9

8.8M sh @ $0.111 · -100.0% own

DTOISS◆—

Wright Robin · DirectorSep 9

20,174 sh

DTOISS◆—

Wright Robin · DirectorSep 9

19,516 sh

DTOISS◆—

Wright Robin · DirectorSep 9

19,197 sh

DTOISS◆—

Wright Robin · DirectorSep 9

18,604 sh

DTOISS◆—

Wright Robin · DirectorSep 9

34,328 sh

DTOISS◆—

Wright Robin · DirectorSep 9

20,394 sh

DTOISS—

Wright Robin · DirectorSep 9

48,256 sh · -100.0% own

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

20,174 sh

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

19,516 sh

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

19,197 sh

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

18,604 sh

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

34,328 sh

DTOISS◆—

Morgon Pierre A. · DirectorSep 9

20,394 sh

DTOISS—

Morgon Pierre A. · DirectorSep 9

10,506 sh · -100.0% own

DTOISS◆—

Phillips Anne M. · DirectorSep 9

20,174 sh

DTOISS◆—

Phillips Anne M. · DirectorSep 9

19,516 sh

DTOISS◆—

Phillips Anne M. · DirectorSep 9

19,197 sh

DTOISS◆—

Phillips Anne M. · DirectorSep 9

18,604 sh

DTOISS◆—

Phillips Anne M. · DirectorSep 9

34,328 sh

DTOISS—

Phillips Anne M. · DirectorSep 9

3,000 sh · -100.0% own

DTOISS◆—

Scheeren Joseph · DirectorSep 9

20,174 sh

DTOISS◆—

Scheeren Joseph · DirectorSep 9

19,516 sh

DTOISS◆—

Scheeren Joseph · DirectorSep 9

19,197 sh

DTOISS◆—

Scheeren Joseph · DirectorSep 9

18,604 sh

DTOISS◆—

Scheeren Joseph · DirectorSep 9

34,328 sh

DTOISS—

Scheeren Joseph · DirectorSep 9

23,000 sh · -100.0% own

DTOISS◆—

Enright William · Chief Executive…Sep 9

600,000 sh

DTOISS◆—

Enright William · Chief Executive…Sep 9

443,981 sh

DTOISS◆—

Enright William · Chief Executive…Sep 9

440,000 sh

DTOISS◆—

Enright William · Chief Executive…Sep 9

359,605 sh

DTOISS◆—

Enright William · Chief Executive…Sep 9

176,130 sh

DTOISS—

Enright William · Chief Executive…Sep 9

514,923 sh · -100.0% own

DTOISS—

Enright William · Chief Executive…Sep 9

728,454 sh · -100.0% own

DTOISS◆—

Hammacher Alex · DirectorSep 9

20,174 sh

DTOISS◆—

Hammacher Alex · DirectorSep 9

19,516 sh

DTOISS◆—

Hammacher Alex · DirectorSep 9

19,197 sh

DTOISS◆—

Hammacher Alex · DirectorSep 9

18,604 sh

DTOISS◆—

Hammacher Alex · DirectorSep 9

34,328 sh

DTOISS—

Hammacher Alex · DirectorSep 9

3,000 sh · -100.0% own

DTOISS◆—

Hooftman Leon · Chief Medical…Sep 9

140,000 sh

DTOISS◆—

Hooftman Leon · Chief Medical…Sep 9

195,166 sh

DTOISS—

Hooftman Leon · Chief Medical…Sep 9

361,530 sh · -100.0% own

AGRANT—

Hooftman Leon · Chief Medical…Sep 9

361,530 sh

DTOISS◆—

Dawes Karen A · DirectorSep 9

20,174 sh

DTOISS◆—

Dawes Karen A · DirectorSep 9

19,516 sh

DTOISS◆—

Dawes Karen A · DirectorSep 9

19,197 sh

DTOISS◆—

Dawes Karen A · DirectorSep 9

18,604 sh

DTOISS◆—

Dawes Karen A · DirectorSep 9

34,328 sh

DTOISS—

Dawes Karen A · DirectorSep 9

1,700 sh · -100.0% own

AGRANT◆—

Hammacher Alex · DirectorJun 10, 2025

20,174 sh

AGRANT◆—

Wright Robin · DirectorJun 10, 2025

20,174 sh

AGRANT◆—

Morgon Pierre A. · DirectorJun 10, 2025

20,174 sh

AGRANT◆—

Phillips Anne M. · DirectorJun 10, 2025

20,174 sh

AGRANT◆—

Scheeren Joseph · DirectorJun 10, 2025

20,174 sh

AGRANT◆—

Dawes Karen A · DirectorJun 10, 2025

20,174 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 14 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →